Provided by Tiger Trade Technology Pte. Ltd.

Immunocore Holdings plc

31.40
-0.3800-1.20%
Volume:124.94K
Turnover:3.93M
Market Cap:1.62B
PE:-88.04
High:32.04
Open:31.67
Low:31.26
Close:31.78
52wk High:40.71
52wk Low:27.56
Shares:51.50M
Float Shares:45.83M
Volume Ratio:0.82
T/O Rate:0.27%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3566
EPS(LYR):-0.7054
ROE:-4.47%
ROA:-0.16%
PB:3.85
PE(LYR):-44.51

Loading ...

Immunocore Completes Enrollment in Phase 3 Melanoma Trial

TIPRANKS
·
Sep 14

Immunocore achieves target patient enrollment in TEBE-AM clinical trial

TIPRANKS
·
Sep 14

Immunocore - Achieves Target Enrollment in Tebe-am Trial with Kimmtrak in Advanced Melanoma

THOMSON REUTERS
·
Sep 14

Immunocore - Topline Overall Survival Data from Tebe-am Trial Expected by End of 2026

THOMSON REUTERS
·
Sep 14

Immunocore Reaches 540-Patient Enrollment Target in Phase 3 TEBE-am Trial of Kimmtrak in Advanced Melanoma

Reuters
·
Sep 14

Immunocore to Present at Cantor Global Healthcare Conference Fireside Chat

Reuters
·
Sep 01

Immunocore Holdings Price Target Announced at $50.00/Share by JP Morgan

Dow Jones
·
Aug 22

Is Immunocore Holdings (IMCR) Undervalued After Stronger Revenue And Profitability Results?

Simply Wall St.
·
Aug 18

Immunocore price target raised to $43 from $40 at Morgan Stanley

TIPRANKS
·
Aug 07

Analysts Offer Insights on Healthcare Companies: Viatris (VTRS), Immunocore Holdings (IMCR) and Praxis Precision Medicines (PRAX)

TIPRANKS
·
Aug 07

Analysts Are Bullish on These Healthcare Stocks: Immunocore Holdings (IMCR), Natera (NTRA)

TIPRANKS
·
Aug 07

Needham Reaffirms Their Buy Rating on Immunocore Holdings (IMCR)

TIPRANKS
·
Aug 06

Immunocore Holdings PLC Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

Immunocore Publishes Corporate Presentation on Bispecific Soluble TCR Platform and Pipeline Across Oncology, Infectious and Autoimmune Diseases

Reuters
·
Aug 06

Earnings Flash (IMCR) Immunocore Posts Q2 Loss $0.02 a Share, vs. FactSet Est of $0.02 Loss

MT Newswires Live
·
Aug 06

UK's Immunocore Q2 EPS Misses Estimates

Reuters
·
Aug 06

Immunocore Q2 FY26 Net Loss Narrows to $0.8 Million; Revenue Rises 18% to $115.9 Million

Reuters
·
Aug 06

Immunocore Hldgs Q2 EPS $(0.02) Misses $0.02 Estimate, Sales $115.927M Beat $110.374M Estimate

Benzinga Earnings
·
Aug 06

Press Release: Immunocore Reports Second Quarter Financial Results and Provides a Business Update

Dow Jones
·
Aug 06

Immunocore Holdings PLC Expected to Post Earnings of 1 Cent a Share - Earnings Preview

Reuters
·
Aug 04